Hong-Sin Kim
Presidente presso Korea Stem Cell Bank Co., Ltd.
Profilo
Hong-Sin Kim is currently the Chairman of Korea Stem Cell Bank Co., Ltd.
and a Professor at Konkuk University.
In the past, he served as an Independent Director at ChoA Pharmaceutical Co., Ltd.
and BIOVILL Co., Ltd.
from 2012 to 2018.
Posizioni attive di Hong-Sin Kim
| Società | Posizione | Inizio |
|---|---|---|
| Konkuk University | Corporate Officer/Principal | - |
Korea Stem Cell Bank Co., Ltd.
 Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Presidente | - |
Precedenti posizioni note di Hong-Sin Kim
| Società | Posizione | Fine |
|---|---|---|
| KSCB CO LTD | Presidente | - |
| CHOA PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
BIOVILL Co., Ltd.
 BIOVILL Co., Ltd. Industrial SpecialtiesProcess Industries BIOVILL Co., Ltd. engages in the manufacture and sale of functional materials. Its products include coloring materials for plastics, inks for plastic printing, surface treatment materials, polyvinyl compound, frame structure, and other products. The company was founded in April 1976 and is headquartered in Yangsan-si, South Korea. | Process Industries |
Korea Stem Cell Bank Co., Ltd.
Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Health Technology |
- Borsa valori
- Insiders
- Hong-Sin Kim
